{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T14:48:54Z","timestamp":1789829334410,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.mehy.2020.110091","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T19:15:40Z","timestamp":1594322140000},"page":"110091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection"],"prefix":"10.1016","volume":"143","author":[{"given":"Hulya","family":"Vatansev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cengiz","family":"Kadiyoran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medine","family":"Cumhur Cure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkan","family":"Cure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"SI-1","key":"10.1016\/j.mehy.2020.110091_b0005","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3906\/sag-2004-160","article-title":"Radiological approaches to COVID-19 pneumonia","volume":"50","author":"Ak\u00e7ay","year":"2020","journal-title":"Turk J Med Sci"},{"key":"10.1016\/j.mehy.2020.110091_b0010","article-title":"Angiotensin 1\u20137 formation in breast tissue is attenuated in breast cancer \u2013 a study on the metabolism of angiotensinogen in breast cancer cell lines","author":"Bujak-Gizycka","year":"2019","journal-title":"J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.mehy.2020.110091_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1177\/1534735414562956","article-title":"Normolipidic dietary fat modifies circulating Renin-Angiotensin system-regulating aminopeptidase activities in rat with breast cancer","volume":"14","author":"Ru\u00edz-Sanjuan","year":"2015","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.mehy.2020.110091_b0020","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25848","article-title":"Comment on \u201cOrgan-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19\u201d","author":"Cure","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/j.mehy.2020.110091_b0025","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.dsx.2020.04.019","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic","volume":"14","author":"Cure","year":"2020","journal-title":"Diabetes Metab Syndr"},{"issue":"1","key":"10.1016\/j.mehy.2020.110091_b0030","doi-asserted-by":"crossref","first-page":"75","DOI":"10.18433\/jpps31069","article-title":"Prevention and therapy of COVID-19 via exogenous estrogen treatment for both male and female patients","volume":"23","author":"Suba","year":"2020","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"10.1016\/j.mehy.2020.110091_b0035","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s13277-014-2713-3","article-title":"Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells","volume":"36","author":"Namazi","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.mehy.2020.110091_b0040","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3389\/fphar.2019.01499","article-title":"Role of estrogen receptors \u03b1 and \u03b2 in a murine model of asthma: exacerbated airway hyperresponsiveness and remodeling in ER\u03b2 knockout mice","volume":"10","author":"Kalidhindi","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.mehy.2020.110091_b0045","article-title":"Potential therapeutic benefit of combining gefitinib and tamoxifen for treating advanced lung adenocarcinoma","volume":"2015","author":"Liu","year":"2015","journal-title":"Biomed Res Int"},{"issue":"24","key":"10.1016\/j.mehy.2020.110091_b0050","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.2174\/092986709788803042","article-title":"The effects of tamoxifen on immunity","volume":"16","author":"Behjati","year":"2009","journal-title":"Curr Med Chem"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698772031330X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698772031330X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:43Z","timestamp":1759692343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698772031330X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":10,"alternative-id":["S030698772031330X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110091","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 infection can cause chemotherapy resistance development in patients with breast cancer and tamoxifen may cause susceptibility to COVID-19 infection","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2020.110091","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110091"}}